Validation of the French Translation of a Self-questionnaire Looking for a History of Pre-eclampsia.

Overview

PRERETRO is a study for validation of the French translation of a self-questionnaire looking for a history of pre-eclampsia of more than 5 years in women who have already had a pregnancy of more than 6 months with childbirth at Brest University Hospital.

Full Title of Study: “Validation of the French Translation of a Self-questionnaire Looking for a History of Pre-eclampsia of More Than 5 Years in Women Who Have Already Had a Pregnancy of More Than 6 Months With Childbirth at Brest University Hospital.”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: June 22, 2021

Detailed Description

This study will help to evaluate the specificity and sensitivity of the French translation of a self-questionnaire looking for a history of pre-eclampsia in women who gave birth at Brest University Hospital before year 2015. First, women with pre-eclampsia (cases) and women with no hypertensive disorders (controls) during pregnancy were identified with the Medical Registry Database (MRD) of Brest University maternity ward. All pre-eclampsia diagnoses were reviewed by 2 experts in order to confirm the accuracy of the diagnosis. 250 cases and 250 controls were finally selected after consultation of their medical file and were pre-included in the study. Then, the 500 women will be contacted by phone or e-mail in order to inform them about the study and to offer them the possibility to participate in the study. The women who will agree to participate in the study will fill in an online self-questionnaire on pre-eclampsia. Their responses will then be compared to the diagnosis retained after consultation of their medical file. Sensitivity and specificity of the questionnaire will then be evaluated.

Interventions

  • Other: administration of a self-questionnaire
    • Women will have to fill in an online self questionnaire on pre-eclampsia

Arms, Groups and Cohorts

  • cases
    • Women with a history of pre-eclampsia
  • controls
    • Women with no history of hypertensive disorder during pregnancy

Clinical Trial Outcome Measures

Primary Measures

  • Evaluate diagnostic sensitivity and specificity of the self questionnaire
    • Time Frame: Inclusion ( Day 0)
    • Presence or not of a history pre-eclampsia according to responses to the questionnaire

Participating in This Clinical Trial

Inclusion Criteria

  • Women who gave birth after a pregnancy of more than 6 months at Brest University Hospital between January 2002 and December 2014 – For the cases: with a pre-eclampsia diagnosis during pregnancy – For the controls: with no history of hypertensive disorder during pregnancy Exclusion Criteria:

  • Women Under legal protection – Women unable to read French – Medical interruption of pregnancy – Pregnancy with a delivery before 6 months – Women who refused to participate in the study

Gender Eligibility: Female

Women who gave birth after a pregnancy of more than 6 months at Brest University Hospital between January 2002 and December 2014

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University Hospital, Brest
  • Provider of Information About this Clinical Study
    • Sponsor

Citations Reporting on Results

Societe francaise d'anesthesie et de reanimation (Sfar); College national des gynecologues et obstetriciens francais (CNGOF); Societe francaise de medecine perinatale (SFMP); Societe francaise de neonatalogie (SFNN). [Multidisciplinary management of severe pre-eclampsia (PE). Experts' guidelines 2008. Societe francaise d'anesthesie et de reanimation. College national des gynecologues et obstetriciens francais. Societe francaise de medecine perinatale. Societe francaise de neonatalogie]. Ann Fr Anesth Reanim. 2009 Mar;28(3):275-81. doi: 10.1016/j.annfar.2009.02.015. Epub 2009 Mar 24. No abstract available. French.

Saucedo M, Deneux-Tharaux C, Bouvier-Colle MH; Le Comite national d'experts sur la mortalite maternelle. [Maternal mortality in France, 2007-2009]. J Gynecol Obstet Biol Reprod (Paris). 2013 Nov;42(7):613-27. doi: 10.1016/j.jgyn.2013.06.011. Epub 2013 Sep 13. French.

Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007 Nov 10;335(7627):974. doi: 10.1136/bmj.39335.385301.BE. Epub 2007 Nov 1.

van Wyk L, van der Marel J, Schuerwegh AJ, Schouffoer AA, Voskuyl AE, Huizinga TW, Bianchi DW, Scherjon SA. Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study. Arthritis Res Ther. 2011;13(6):R183. doi: 10.1186/ar3510. Epub 2011 Nov 4.

Kamper-Jorgensen M, Gammill HS, Nelson JL. Preeclampsia and scleroderma: a prospective nationwide analysis. Acta Obstet Gynecol Scand. 2018 May;97(5):587-590. doi: 10.1111/aogs.13296. Epub 2018 Feb 8.

Diehl CL, Brost BC, Hogan MC, Elesber AA, Offord KP, Turner ST, Garovic VD. Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire. Am J Obstet Gynecol. 2008 May;198(5):e11-3. doi: 10.1016/j.ajog.2007.09.038. Epub 2008 Feb 1.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.